Evidence map›Paper›PMID 29021229›Full record

ArticleBlood2017

In vivo-generated thrombin and plasmin do not activate the complement system in baboons.

Ravi S Keshari, Robert Silasi, Cristina Lupu, Fletcher B Taylor, Florea Lupu

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Disseminated intravascular coagulation.Journal of intensive care · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Enolase FromFrontiers in immunology · 2019
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ravi S KeshariCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0002-4177-9095
Robert SilasiCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0001-9590-6160
Cristina LupuCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0001-8619-0893
Fletcher B TaylorCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Florea LupuCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0003-1249-9278
Oklahoma Medical Research Foundation · US

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
SWI/SNF-REGULATED POSTNATAL ANGIOGENESISP20RR018758 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL · 2003 to 2011
$14.9M
Pilot ProjectP30GM114731 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL · 2016 to 2020
$6.5M
Complement inhibition as sepsis therapyR01GM097747 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LAMBRIS, JOHN D, LUPU, FLOREA · 2011 to 2014
$2.1M
FXI and SepsisR01GM116184 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LUPU, FLOREA, MCCARTY, OWEN J · 2015 to 2018
$1.9M
Coagulation and Complement Activation in SepsisR01GM121601 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LUPU, FLOREA · 2017 to 2020
$1.6M
NCRR NIH HHS P20 RR018758NIAID NIH HHS U19 AI062629NIGMS NIH HHS P30 GM114731NIGMS NIH HHS R01 GM097747NIGMS NIH HHS R01 GM116184NIGMS NIH HHS R01 GM121601
6 · The paper itself

Abstract

Sepsis concurrently activates both coagulation and complement systems. Although complement activation by bacteria is well documented, work in mice and in vitro suggests that coagulation proteases can directly cleave complement proteins. We aimed to determine whether generation of coagulation proteases in vivo can activate the complement cascade in 2 highly coagulopathic models. We compared temporal changes in activation biomarkers of coagulation (thrombin-antithrombin [TAT]), fibrinolysis (plasmin-antiplasmin [PAP]), and complement (C3b, C5a, C5b-9) in baboons infused with factor Xa (FXa) and phospholipids (FXa/phosphatidylcholine-phosphatidylserine [PCPS]) vs LD100

Indexed as

AnimalsComplement ActivationComplement System ProteinsEscherichia coliFactor XaFibrinolysinHumansLipopolysaccharidesPapioPhosphatidylcholinesPhosphatidylserinesThrombinComplement System ProteinsFactor XaFibrinolysinLipopolysaccharidesPhosphatidylcholinesPhosphatidylserinesThrombin

Identifiers

PMID29021229
PMCPMC5731087
OpenAlexW2763955483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.